If Nox4 is shown to be involved in the aging process in the heart, it could be a promising target of pharmacological intervention because aging-induced cardiomyopathy remarkably enhances the patient's risk of developing heart failure in response to many cardiac conditions, including high blood pressure, ischemia, and diabetes. This evidence concerns the gene NOX4 and cardiomyopathy.